Company profile

AC BioScience SA

AC BioScience Ltd is a biotechnology company dedicated to developing innovative therapies to fight infectious and inflammatory diseases, and companion products for the treatment of tumoral and immunological pathologies. These products also include the development of adjuvant or neo-adjuvant therapies for cancer treatment.

Source: startup.ch

More news about AC BioScience SA

26.08.2022 14:00

AC BioScience closes CHF 2.5 million seed round

Financing

21.03.2022 12:01

Seasoned Board Members for Swiss Startups

Success

18.12.2020 11:29

AC BioScience moves towards clinical trials

Financing

25.05.2020 12:06

Additional capital for AC BioScience

Financing

01.04.2019 16:45

Swiss Biotech Day to shed light on 13 emerging startups

Background

Support

13.03.2019 11:42

AC Bioscience secures CHF 1 million in a seed round

Financing

Founded
2017

Kanton
VD

Homepage

Principal

Swiss Venture Capital Report

The new Swiss Venture Capital Report provides a review of the whole of 2023. In addition to investments, the report will once again include the results of a survey of Swiss investors, an overview of venture capital fundraising and a list of exits. You can download the Report in our asset section.